Global Blood Collection Devices Market Set to Achieve a Solid 7% CAGR during 2021-2026

 

Rising trauma and accident cases, increased surgical procedures globally, rapid growth of infectious diseases, government blood donation programs, and increasing adoption of liquid biopsy tests are some of the major trends driving the worldwide blood collection devices market.

Blood collection or removal of blood can be accomplished in a variety of methods, including arterial sampling, venipuncture, and fingerstick sampling. To fully understand, prevent, and cure disorders, blood and other biological samples must be collected. Furthermore, blood is received from donors through the blood donation procedure and then separated into different components of blood as needed during transfusion operations.

Creating Newer Product Development to Grow Market Adoption of Blood Collection Devices

Continuous advancements in blood collection technologies have allowed for the creation of effective solutions that include artificial intelligence (AI), ultrasound-guided 3D reconstruction, ease-of-use at-home collection, and large-volume safe blood collection, among other things. The following are some of the new product developments:

  • In May 2022, Vitestro has introduced their breakthrough autonomous venipuncture blood collection equipment, which blends artificial intelligence (AI) with robotic needle insertion and ultrasound-guided 3D reconstruction to ensure safe and exact blood collection.
  • In May 2022, Through Labcorp OnDemand, Labcorp released an at-home collection equipment from Weavr Health, a diagnostics firm, that analyzes HbA1c from a tiny blood sample for diabetes risk testing.
  • In April 2022, Owen Mumford Ltd launched a portfolio of three venous blood collection devices under its Unistik brand. These three devices, namely, Unistik ShieldLock, Unistik ShieldLock Ultra, and Unistik VacuFlip are designed to draw large volumes of blood safely, minimizing the risk of needlestick injury (NSI).
  • In February 2022, Streck launched RNA Complete BCT, a new blood collection tube that maintains draw time cell-free RNA concentration for up to seven days when stored at room temperature providing a convenient method for sample collection, storage, and transport.

Explore Customized Blood Collection Devices Market Insights @ https://www.globenewswire.com/en/news-release/2022/08/02/2490564/0/en/Global-Blood-Collection-Devices-Market-is-set-to-witness-a-decent-CAGR-of-7-from-2021-to-2026-Growing-Adoption-of-Liquid-Biopsy-Tests.html

Blood Collection Devices Market Growth is Poised to grow with the help of Investments and Collaborations

Participants in the blood collection device market are constantly focusing on investments and collaboration to enhance novel blood collection technologies. Manufacturers acquire a competitive edge as a result of such advancements. Some recent advancements are as follows:

  • In May 2022, Becton, Dickinson and Company expanded its relationship with Babson Diagnostics to continue research and development of less-invasive, more convenient, and self-collection blood collection equipment.
  • In December 2021, Tasso has received a $100 million investment to ramp up manufacture and marketing of their simpler 'OnDemand' blood collection systems. Tasso's OnDemand devices draw blood from the skin via capillaries using push-button hardware affixed to the upper arm.
  • In May 2019, Intermountain Healthcare has invested $10 million in Velano Vascular to help it commercialize its vascular access solutions, which include a needle-free blood collection device.

Competitive Landscape Analysis: Blood Collection Devices Market

The global blood collection devices market is marked by the presence of major market players such as Becton, Dickinson and Company (US); Terumo BCT (US); Haemonetics Corporation (US); Grifols, S.A. (Spain); Fresenius Kabi AG (Germany); and others.

Explore Detailed Insights on Blood Collection Devices Market @ https://meditechinsights.com/blood-collection-devices-market/

Comments

Post a Comment

Popular posts from this blog

The Transplantation Market Anticipated to Expand with 9-10% CAGR by 2029 as Need for Organ Transplants Rises

Image
  The market is propelled by various factors, including advancements in medical technology, the rising prevalence of chronic diseases that lead to organ failure, increasing awareness of transplantation as a viable treatment option, and evolving regulatory and reimbursement policies. In medical terms, transplantation refers to the surgical procedure of transferring cells, tissues, or organs from a donor to a recipient to replace malfunctioning or damaged body parts. Its primary goal is to restore normal function or improve the quality of life for the recipient. Transplantation is often used to treat end-stage organ failure, severe injuries, certain cancers, and congenital defects that are not manageable through other medical treatments. This specialized field requires careful matching of donors and recipients, advanced surgical techniques, and comprehensive post-transplant care to ensure success. Types of transplantation include: Kidney Transplantation: Involves replacing a fail...
Read more

Global MedTech CMO Market to Witness a Robust Annual Growth Rate of 11%.

Image
  Due to increased outsourcing by OEMs and higher growth rates in segments like Drug delivery and MIS (Minimally Invasive Surgery). Additionally, the growing burden of chronic diseases, the rising demand for cost-effective medical devices and the increasing complexity of regulatory requirements, further drives the MedTech CMO market. The MedTech CMO (Contract Manufacturing Organization) market involves outsourcing the manufacturing of medical devices and equipment to specialized third-party organizations. Get A Free PDF Sample of Our Research Report : https://meditechinsights.com/medtech-cmo-market/request-sample/ The Strategic Benefits Fueling MedTech Companies' Shift to CMO Services The decision to engage Contract Manufacturing Organization (CMO) services is primarily driven by the need to reduce costs and improve operational efficiency. CMOs provide substantial cost advantages, enabling medical device companies to reduce capital expenditure on manufacturing infrastructure and l...
Read more

The Fluoroscopy Equipment Market Grows Steadily, Anticipated to Achieve a CAGR of 5-7%

Image
  Key Drivers of Market Growth: Technological Advancements, Chronic Disease Incidence, and Aging Demographics Recent innovations in fluoroscopy, such as digital imaging, dose reduction methods, and multimodal integration, have significantly improved image quality, patient safety, and procedural efficiency. The rise in chronic conditions like cardiovascular disease, gastrointestinal issues, and orthopedic ailments underscores the need for advanced imaging solutions like fluoroscopy, which aids in diagnosing and treating these conditions. Furthermore, the aging global population has led to an increased need for diagnostic imaging to manage age-related health issues, and the use of fluoroscopy in minimally invasive procedures in specialties such as cardiology, orthopedics, oncology, and urology is expanding. Increased healthcare spending, paired with the evolution of medical technology and favorable reimbursement policies, is further driving the adoption of fluoroscopy equipment world...
Read more